Glenmede Trust CO Na Baxter International Inc Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Baxter International Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 31,961 shares of BAX stock, worth $985,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,961

Previous 75,843 57.86%

Holding current value

$985,038

Previous $2.88 Million 67.66%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$28.63 - $37.84 $1.26 Million - $1.66 Million	-43,882 Reduced 57.86%	31,961 $931,000
Q3 2024 Nov 13, 2024	BUY	$32.85 - $40.26 $55,910 - $68,522	1,702 Added 2.3%	75,843 $2.88 Million
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $973,346 - $1.29 Million	-29,612 Reduced 28.54%	74,141 $2.48 Million
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $2.55 Million - $2.95 Million	-67,388 Reduced 39.38%	103,753 $4.43 Million
Q4 2023 Feb 13, 2024	SELL	$31.71 - $38.95 $4.33 Million - $5.32 Million	-136,497 Reduced 44.37%	171,141 $6.62 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $3.7 Million - $4.89 Million	-99,163 Reduced 24.38%	307,638 $11.6 Million
Q1 2023 May 15, 2023	SELL	$37.58 - $52.57 $1.96 Million - $2.75 Million	-52,242 Reduced 11.38%	406,801 $16.5 Million
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $468,024 - $543,455	-9,417 Reduced 2.01%	459,043 $23.4 Million
Q3 2022 Nov 16, 2022	SELL	$53.86 - $66.8 $482,639 - $598,594	-8,961 Reduced 1.88%	468,460 $25.2 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $1.12 Million - $1.4 Million	-17,483 Reduced 3.53%	477,421 $30.7 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $195,199 - $227,203	-2,540 Reduced 0.51%	494,904 $38.4 Million
Q4 2021 Feb 15, 2022	SELL	$74.57 - $87.19 $694,768 - $812,349	-9,317 Reduced 1.84%	497,444 $42.7 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $620,700 - $703,494	-8,414 Reduced 1.63%	506,761 $40.8 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $653,821 - $714,817	-8,122 Reduced 1.55%	515,175 $41.5 Million
Q1 2021 May 18, 2021	SELL	$76.38 - $86.03 $133,130 - $149,950	-1,743 Reduced 0.33%	523,297 $44.1 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $137,435 - $150,142	-1,823 Reduced 0.35%	525,040 $42.1 Million
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $352,171 - $407,922	-4,496 Reduced 0.85%	526,863 $42.4 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $2.83 Million - $3.39 Million	-35,988 Reduced 6.34%	531,359 $45.7 Million
Q4 2019 Feb 12, 2020	SELL	$76.7 - $88.45 $15.1 Million - $17.4 Million	-196,580 Reduced 25.73%	567,347 $47.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $17.4 Million - $19.1 Million	213,216 Added 38.72%	763,927 $66.8 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $423,455 - $475,176	-5,766 Reduced 1.04%	550,711 $45.1 Million
Q1 2019 May 14, 2019	SELL	$64.48 - $81.31 $4.14 Million - $5.23 Million	-64,279 Reduced 10.35%	556,477 $45.2 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $1.32 Million - $1.67 Million	-21,478 Reduced 3.34%	620,756 $40.9 Million
Q3 2018 Nov 15, 2018	BUY	$70.71 - $77.75 $1.03 Million - $1.13 Million	14,559 Added 2.32%	642,234 $49.5 Million
Q2 2018 Aug 15, 2018	SELL	$63.43 - $75.41 $1.35 Million - $1.61 Million	-21,347 Reduced 3.29%	627,675 $46.3 Million
Q4 2017 Feb 15, 2018	SELL	$61.45 - $66.05 $6.15 Million - $6.61 Million	-100,023 Reduced 13.35%	649,022 $42 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $44.6 Million - $48.4 Million	749,045	749,045 $0

Others Institutions Holding BAX

# of Institutions

938

Shares Held

469M

Call Options Held

2.33M

Put Options Held

3.52M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $15.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Baxter International Inc Transaction History